A variety of exclusion criteria (e.g., history of repeated strokes, repeated head trauma, encephalitis, neuroleptic use and abnormal neuroimaging) as well as supportive criteria (e.g., unilateral onset and levodopa responsiveness) can help to weaken or strengthen the presumptive diagnosis. Nevertheless, clinicopathologic studies have demonstrated that even in the best of hands the correct diagnosis is missed in approximately 20% of cases. 2, 3 Disorders like progressive supranuclear palsy and the multiple systems atrophy syndromes (i.e., striatonigral degeneration, olivopontocerebellar atrophy, Shy-Drager syndrome, corticobasal degeneration) make up the remaining 20% that are often misdiagnosed.
The importance of making the correct diagnosis is at least three-fold: apraxia. Knowing the correct diagnosis allows the treating physician to deal proactiv with issues such as quality of life, feeding and other end-of-life questions that will almost certainly come sooner than later compared to idiopathic PD.
Medical treatment:
The atypical parkinsonian disorders are generally unresponsive to pharmacotherapy. Having a tool to help confirm or reject the diagnosis of PD would clearly help guide rational medical management. If such a tool would be suggestive of idiopathic PD, the clinician might be inclined to be more aggressive in treatment, as typical PD can be expected to respond to at least one of the many pharmacologic options available. In contrast, a decision to limit trials of medication might be made with the atypical syndromes-thus sparing the patient from unwanted side-effects, ineffective results and unnecessary cost.
3. Surgical treatment: Deep Brain Stimulation is one of the most important modalities for treating PD since the advent of levodopa in the late 1960's. However, results from several studies make it clear that benefit from this invasive and potentially risky procedure is dependent upon 2 factors: proper diagnosis of PD and precise localization of the stimulating electrode. Patients with any of the atypical parkinsonian syndromes do not benefit from deep brain stimulation, and it is crucial to have an accurate diagnosis prior to surgery.
